Christine Mary Charney, MA - Counselor in Johnstown, PA

Christine Mary Charney, MA is a Counselor based in Johnstown, Pennsylvania. Christine Mary Charney is licensed to practice in * (Not Available) (license number ) and her current practice location is 131 Market St, Johnstown, Pennsylvania. She can be reached at her office (for appointments etc.) via phone at (814) 534-0745.

NPI number for Christine Mary Charney is 1023280351 and her current mailing address is 131 Market St, Johnstown, Pennsylvania. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1023280351.

Contact Information

Christine Mary Charney, MA
131 Market St,
Johnstown, PA 15901-1628
(814) 534-0745
(814) 536-5431

Healthcare Provider's Profile

Full NameChristine Mary Charney
GenderFemale
SpecialityCounselor
Location131 Market St, Johnstown, Pennsylvania
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1023280351
  • Provider Enumeration Date: 03/26/2008
  • Last Update Date: 03/26/2008

Medical Identifiers

Medical identifiers for Christine Mary Charney such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023280351NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
101Y00000XCounselor (* (Not Available))Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Christine Mary Charney is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Christine Mary Charney, MA
131 Market St,
Johnstown, PA 15901-1628

Ph: (814) 534-0745
Christine Mary Charney, MA
131 Market St,
Johnstown, PA 15901-1628

Ph: (814) 534-0745

News Archive

Fidaxomicin, CDA1/CDB1 effective for treating CDI : Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in first- and second-line treatment of Clostridium difficile infection, nearly 70 percent of surveyed infectious disease specialists and internists will use Optimer's fidaxomicin and nearly half will use Medarex/Merck's CDA1 and CDB1, one year after the launch of these agents. The lower recurrent/relapse rate associated with fidaxomicin and CDA1/CDB1 is the most influential attribute surveyed clinicians cite in their decisions to prescribe these emerging agents for CDI.

Drugmakers are 'under-exposed' in emerging markets, report says

Growing markets for pharmaceuticals in China, Brazil, Russia and India are outpacing national markets in Europe and the U.S., but major drugmakers have been slow to expand in these markets and may lose opportunities, a new study finds, The New York Times reports. To put the shift in perspective, China will overtake both France and Germany next year in terms of drug spending, while Brazil will overtake Britain, according to the report by research firm IMS Health.

New ASH report outlines several models for 'systems-based clinical hematologist'

A report released today from the American Society of Hematology in its journal, Blood, presents an innovative, sustainable new role for hematologists, particularly those specializing in non-malignant blood diseases, for today's rapidly changing U.S. health-care system.

Temple University professionals focus on community viral load to combat HIV

World AIDS Day is December 1, but healthcare professionals at Temple University work year-round to combat HIV by focusing on reducing the community viral load, or the severity of HIV in a particular group. This approach has become widespread in the past two years, and it is still evolving and undergoing evaluation.

Read more News

› Verified 9 days ago


Counselor in Johnstown, PA

Corey Larue,
Counselor
Medicare: Medicare Enrolled
Practice Location: 119 Walnut St, Johnstown, PA 15901
Phone: 814-534-0745    
William Martin O'herrick, BSED
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 131 Market St, Johnstown, PA 15901
Phone: 814-535-2277    
Tammy Zeek,
Counselor
Medicare: Medicare Enrolled
Practice Location: 119 Walnut St, Johnstown, PA 15901
Phone: 814-534-0745    
Zita Burnheimer,
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 188 Gilbert St, Johnstown, PA 15906
Phone: 814-539-7339    Fax: 814-535-2219
Jennifer Theresa Stevens, M.S.
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 131 Market St, Johnstown, PA 15901
Phone: 814-535-2277    Fax: 814-539-0475
Neha Rajan, MA
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 865 Eisenhower Blvd, Johnstown, PA 15904
Phone: 814-266-8840    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.